期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

精神分裂症患者血清S100B蛋白检测的临床意义 被引量：4

原文传递
导出
摘要 目的 探讨精神分裂症患者血清S100B蛋白检测的临床意义. 方法 对87例（观察组）临床初诊的精神分裂症患者血清S100B蛋白水平进行检测,并与80名健康者（对照组）进行比较. 结果 观察组S100B蛋白水平明显高于对照组（P＜0.01）;观察组治疗前后S100B蛋白水平差异无统计学意义（P＞0.05）;治疗后血清S100B继续增高组阴性症状评分明显高于治疗后恢复至正常水平组（P＜0.01）. 结论 血清S100B水平与精神分裂症患者阴性症状关联,可能是精神分裂症活动性的标志物.
作者 高鹏
机构地区 济宁市精神病防治院检验科
出处 《中国基层医药》 CAS 2010年第16期2238-2238,共1页 Chinese Journal of Primary Medicine and Pharmacy
关键词 精神分裂症 S100B蛋自
分类号 R74 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献6

二级参考文献33

  • 1凌四海,郭实士,杨铁生,王传跃,汤宜朗,蔡焯基,翁永振.精神分裂症患者血中S100b蛋白和抗脑抗体的研究[J].中国神经精神疾病杂志,2005,31(4):278-281. 被引量：17
  • 2Poyurovsky M, Pashinian A, Gil-Ad I, et al. Olanzapine-induced weight gain in patients with first-episode sehizophrenia:a doubleblind, placebo-controlled study of fluoxetine addition. Am J Psy chiatry,2002,159(6) : 1058-1060.
  • 3Kinon MJ, Basson BR, Tollefson GD. Effect of long-term olanzapine treatment on weight change in schizophrenia: Schizophr Res, 2000,41(Suppl 1 ) :B54.
  • 4Potenza MN, Holmes JP, Kanes SJ, et al. Olanzapine treatment of children, adolescents and adults with pervasive developmental disorder: open-label pilot study. J Clin Psychopharmacol, 1999, 19 (1):37-44.
  • 5Sacchetti E, Guarneri L, Bravi D. H2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biol Psychiatry, 2000,48 (2) : 167-168.
  • 6Van-Beveren, NJ van-der-Spelt, JJde-Haan, et al. Schizophrenia neural growth factors in peripheral blood. A review[ J]. Eur Neuropsychopharmacol, 2006, 16 ( 7 ) :469 - 480.
  • 7Yu Tanaka, Chic Koizumi, Toshiyuki Marumo, et al. Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models [ J ]. Life Sci, 2007, 81(8) :657 -663.
  • 8Manev H, Manev R. SIOOB: an old neurotrophic factor with putative new roles in psychiatric illnesses[ J]. J Psychiatry Res, 2001, 35(6) :347 -350.
  • 9Griffin WS, Stanley EC, Ling C, et al. Brain interleukin 1 and S- 100 immunoreactivity are elevated in Down syndrome and Alzheimer disease[J]. PANS, 1989, 86(19) :7611 -7619.
  • 10Rothermundt M, Ohrmann P, Abel S, et al. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased SIOOB serum concentrations and elevated myo-inositol [ J]. Progress in Neuro-psychopharmacoloy and Biological psychiatry, 2007, 31(2) :361 -364.

共引文献20

同被引文献47

  • 1王薇薇,王新德.第六届全国脑血管病学术会议纪要[J].中华神经科杂志,2004,37(4):346-348. 被引量：300
  • 2袁玉美,徐乃军,刘延波,霍淑芳.新生儿缺氧缺血性脑病血清CKBB、LDH3活性检测[J].临床儿科杂志,2004,22(10):685-687. 被引量：7
  • 3中华医学会儿科学分会新生儿学组.新生儿缺氧缺血性脑病诊断标准[J].中华儿科杂志,2005,43(8):584-584. 被引量：1298
  • 4王鹏高,施新革,赵文增.S100蛋白与体外循环脑损伤[J].新乡医学院学报,2006,23(4):426-428. 被引量：8
  • 5Kleindienst A, Meissner S, Eyupoglu IY, et al. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Acta Neurochir, 2010,106 Suppl:S247-250.
  • 6Ravasi T,Hsu K, Goyette J,et al. Probing the S100 protein family through genomic and functional analysis. Genomics, 2004, 84: 10- 22.
  • 7Rainey T, Lesko M, Sacho R,et al. Predicting outcome after severe traumatic brain injury using the serum SI00B biomarker: results using a single (24h) time-point. Resuscitation, 2009,80 (3) : 341- 345.
  • 8Nagdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res, 2001,49 ( 4 ) : 502-506.
  • 9Cazzolo D, Marinoni E, Dilorio R. Urinary S100B protein measurements:a tool for the early identification of hypoxicisehemic cncephalopathy in asphyxiated full-terminfants. Crit Care Med, 2004, 32( 1 ) : 134-136.
  • 10Lalousche KW, Endler TG, Sehillinger M, et al. Candidate genetic risk factors of stroke: Results of a multilocus genotyping assay. Clin Chem,2007,53 (4) :600-605.

引证文献4

二级引证文献58

中国基层医药
2010年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部